EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated homocysteine associated with higher cardiovascular risk in young patients with myocardial infarction: the role of metabolic phenotypes

Jing-Yu Liu, Yu-Hang Wang, Chang-Ping Li, Zhuang Cui, Yin Liu, Jing Gao

Frontiers in Endocrinology · 2026

DOI: 10.3389/fendo.2026.1821132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Jing-Yu Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical School of Thoracic, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Homocysteine, Myocardial Infarction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Premature myocardial infarction (PMI) is increasingly recognized as a metabolic disease, driven by a cluster of dysregulations including insulin resistance and central obesity. While homocysteine (Hcy)—an intermediate of one-carbon metabolism—is implicated in these atherothrombotic processes, its synergistic effect with coexisting cardiometabolic risk factors for the long-term prognosis of PMI patients remains unclear.

Methods

We conducted a prospective cohort study of 1,220 consecutive PMI patients who underwent percutaneous coronary intervention (PCI) (men ≤45 years, women ≤55 years) at Tianjin Chest Hospital from January 2017 to December 2024. Plasma Hcy was measured at baseline and classified as high (≥15 µmol/L) or normal (<15 µmol/L). The primary endpoint was major adverse cardiovascular events (MACE), including cardiac death, rehospitalization for severe heart failure, non-fatal myocardial infarction, ischemic stroke, readmission for unstable angina, and target lesion revascularization. Multivariable Cox models and joint effect analyses were used to assess independent and synergistic associations.

Results

Over a median follow-up of 582 days, 136 patients (11.1%) experienced MACE. After multivariable adjustment, high Hcy remained independently associated with MACE (aHR=2.72; 95% CI 1.87-3.95, P<0.001). This risk was higher when cardiometabolic factors coexisted, increasing from a 3.1-to 4.1-fold higher risk when combined with high D-Dimer, high-normal blood pressure, Lp(a), or hs-CRP (aHRs 3.13-4.12), to a 6.5-fold higher risk with coexisting obesity (aHR=6.54; 95% CI 3.01-14.20, P<0.001) compared to patients with normal Hcy and normal BMI. In the exploratory three-way analyses, the combination of high Hcy, obesity, and elevated D-Dimer (D-Dimer>0.5mg/L) conferred a nearly 10-fold higher risk (aHR=9.91; 95% CI 3.68–26.66, P<0.001), while the triad of high Hcy, obesity, and high hs-CRP (hs-CRP >2 mg/L) was associated with a 17.5-fold higher risk (aHR=17.51; 95% CI 2.28-134.52, P=0.006).

Conclusion

Elevated plasma Hcy is an independent predictor of MACE in PMI patients and may be used to identify subgroups at particularly high risk. This effect is more pronounced in individuals who are obese or have other adverse metabolic characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HomocysteineMyocardial InfarctionHumansFemaleProspective StudiesMiddle AgedMalePhenotypeAdultPrognosisRisk FactorsBiomarkersPercutaneous Coronary Intervention

Stichwörter der Autor:innen

homocysteinemetabolic syndromeobesitypremature myocardial infarctionrisk stratification

Substanzen

HomocysteineBiomarkers

Autor:innen und Institutionen

  • Clinical School of Thoracic, Tianjin Medical University, Tianjin, China.
  • Department of Cardiology, Tianjin Chest Hospital, Tianjin, China.
  • School of Public Health, Tianjin Medical University, Tianjin, China.
  • Chest Hospital, Tianjin University, Tianjin, China.
  • Cardiovascular Institute, Tianjin Chest Hospital, Tianjin, China.
  • Tianjin Key Laboratory of Cardiovascular Emergency and Critical Care, Tianjin, China.

Zitieren

APA

Liu, J. Y., Wang, Y. H., Li, C. P., Cui, Z., Liu, Y., & Gao, J. (2026). Elevated homocysteine associated with higher cardiovascular risk in young patients with myocardial infarction: the role of metabolic phenotypes. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1821132

Vancouver

Liu JY, Wang YH, Li CP, Cui Z, Liu Y, Gao J. Elevated homocysteine associated with higher cardiovascular risk in young patients with myocardial infarction: the role of metabolic phenotypes. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1821132

BibTeX
@article{Liu2026,
  author = {Liu, Jing-Yu and Wang, Yu-Hang and Li, Chang-Ping and Cui, Zhuang and Liu, Yin and Gao, Jing},
  title = {Elevated homocysteine associated with higher cardiovascular risk in young patients with myocardial infarction: the role of metabolic phenotypes},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  doi = {10.3389/fendo.2026.1821132}
}
Kostenlos starten →